ArticleBreast cancer research : BCR2021

Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy.

Mariya Rozenblit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.